Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GLP-1RA and LNG-IUD in Obese Patients With Endometrioid Intraepithelial Neoplasia
NCT07107334Phase 2Recruiting
- Sponsor
- University of Florida
- Start
- Apr 2026
- Primary completion
- Nov 2028
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial in endometrioid endometrial adenocarcinoma (EEC) and Endometrial intraepithelial neoplasia (EIN), sponsored by University of Florida. Primary endpoints: Time from start of GLP-1RA to clearance of staging hysterectomy at 12 months, Time from start of GLP-1RA to clearance for pregnancy pursuit at 12 months and 1 more. Started Apr 2026; status: recruiting.
02
Conditions
endometrioid endometrial adenocarcinoma (EEC)Endometrial intraepithelial neoplasia (EIN)
Beyond the preview
Go deeper on NCT07107334.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07107334.